title: The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk.
abstract: Hemoglobin A1c (HbA1c) is a widely used tool for diagnosing, screening, and managing patients with diabetes; however, proper application and interpretation of the HbA1c test is crucial to master for accurate assessment of patients. It also has become the standard test in population-based studies for evaluating the relationship between glycemic control and cardiovascular risk. Results from large clinical trials support the modern perspective that the HbA1c target should be personalized according to the risks and benefits of glycemic control. This likely is most important in patients with diabetes and elevated cardiovascular risk in whom achieving low HbA1c levels early in the natural history may be the most beneficial.
authors.affiliation: Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. E-mail: cnsandler@partners.org.
authors.forename: Courtney Nagel
authors.initials: CN
authors.lastname: Sandler
authors.affiliation: Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
authors.forename: Marie E
authors.initials: ME
authors.lastname: McDonnell
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology*; D048909:Diabetes Complications / Q000209:etiology*; D003920:Diabetes Mellitus / Q000097:blood*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human